Industry Research Reports
Home > Reports > Pharma & Healthcare > Global Pharmaceutical Intermediates Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Global Pharmaceutical Intermediates Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Pharmaceutical Intermediates Market Size(US$)
CAGR 2024-2030
6.3%
Market Size,2030
USD 280,690
Million
Market Snapshot
Market Size in 2024 (Value)
US$ 194,550 million
Market Forecast in 2030(Value)
US$ 280,690 million
CAGR
6.3%
Years Considered
2019-2030
Base Year
2024
Forecast Period
2024-2030
Source: Secondary research, interviews with experts, and QYResearch analysis
Pharmaceutical intermediates are chemical material or chemical products, which could be applied in production of active pharmaceutical ingredients. Their production needs not production certification and they can be produced in ordinary chemical factory. There are many kinds of pharmaceutical intermediates, such as cephalosporin intermediates, vitamin intermediates, quinolones intermediates, steroid intermediates, etc.
The global Pharmaceutical Intermediates market size was US$ 182100 million in 2023 and is forecast to a readjusted size of US$ 280690 million by 2030 with a CAGR of 6.3% during the forecast period 2024-2030.
Global Pharmaceutical Intermediates key players include Wartsila, Hyundai, MAN, MES, Caterpillar, etc. Global top three manufacturers hold a share over 45%.
China is the largest production area, with a share about 30%, followed by India and North America, both have a share over 40 percent.
In terms of product, GMP is the largest segment, with a share over 80%. And in terms of application, the largest application is Antibiotics, followed by Antipyretic analgesics, etc.
In terms of sales (consumption) side, this report focuses on the sales of Pharmaceutical Intermediates by regions (Countries), company, by type and by type. from 2019 to 2024 and forecast to 2030.
The global Pharmaceutical Intermediates market is thoroughly, accurately, and comprehensively assessed in the report with a large focus on market dynamics, market competition, regional growth, segmental analysis, and key growth strategies. Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of sales analysis, the authors of the report have provided reliable estimations and calculations for global revenue and sales by type segment of the global Pharmaceutical Intermediates market. These figures have been provided in terms of both revenue and sales for the period 2019-2030. Additionally, the report provides accurate figures for sales by region in terms of revenue as well as volume for the same period.
MARKET SEGMENTATION
By Company
- Lonza
- Catalent
- Patheon
- Jubilant
- Granules
- Ganesh
- Chemcon
- BASF
- Porton
- Lianhetech
- ABA Chem
- Tianma
- Jiujiujiu
- Alpha
- Jiuzhou
- Yongtai
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- GMP
- Non-GMP
Segment by Application
- Antibiotics
- Antipyretic Analgesics
- Vitamins
- Others
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Pharmaceutical Intermediates in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3: Detailed analysis of Pharmaceutical Intermediates manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 7: Europe by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 8: China by company, by type and by application, sales, and revenue for each segment.
Chapter 9: APAC (excluding China) by company, by type, by application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pharmaceutical Intermediates sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Report Overview
1.1 Pharmaceutical Intermediates Definition
1.2 Market by Type
1.2.1 Global Pharmaceutical Intermediates Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 GMP
1.2.3 Non-GMP
1.3 Market Segment by Application
1.3.1 Global Pharmaceutical Intermediates Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Antibiotics
1.3.3 Antipyretic Analgesics
1.3.4 Vitamins
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Pharmaceutical Intermediates Sales
2.1 Global Pharmaceutical Intermediates Revenue Estimates and Forecasts 2019-2030
2.2 Global Pharmaceutical Intermediates Revenue by Region: 2019 VS 2023 VS 2030
2.3 Global Pharmaceutical Intermediates Revenue by Region
2.3.1 Global Pharmaceutical Intermediates Revenue by Region (2019-2024)
2.3.2 Global Pharmaceutical Intermediates Revenue by Region (2025-2030)
2.4 Global Pharmaceutical Intermediates Sales Quantity Estimates and Forecasts 2019-2030
2.5 Global Pharmaceutical Intermediates Sales Quantity by Region: 2019 VS 2023 VS 2030
2.6 Global Pharmaceutical Intermediates Sales Quantity by Region
2.6.1 Global Pharmaceutical Intermediates Sales Quantity by Region (2019-2024)
2.6.2 Global Pharmaceutical Intermediates Sales Quantity by Region (2025-2030)
2.7 North America
2.8 Europe
2.9 China
2.10 APAC (excluding China)
2.11 Middle East, Africa and Latin America
3 Competition by Manufacturers
3.1 Global Pharmaceutical Intermediates Sales Quantity by Manufacturers
3.1.1 Global Pharmaceutical Intermediates Sales Quantity by Manufacturers (2019-2024)
3.1.2 Global Pharmaceutical Intermediates Sales Quantity Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Companies by Pharmaceutical Intermediates Sales in 2023
3.2 Global Pharmaceutical Intermediates Revenue by Manufacturers
3.2.1 Global Pharmaceutical Intermediates Revenue by Manufacturers (2019-2024)
3.2.2 Global Pharmaceutical Intermediates Revenue Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Pharmaceutical Intermediates Revenue in 2023
3.3 Global Pharmaceutical Intermediates Sales Price by Manufacturers
3.4 Global Key Players of Pharmaceutical Intermediates, Industry Ranking, 2022 VS 2023
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Pharmaceutical Intermediates Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Pharmaceutical Intermediates, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Pharmaceutical Intermediates, Product Offered and Application
3.8 Global Key Manufacturers of Pharmaceutical Intermediates, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Estimates and Forecasts by Type
4.1 Global Pharmaceutical Intermediates Sales Quantity by Type
4.1.1 Global Pharmaceutical Intermediates Historical Sales Quantity by Type (2019-2024)
4.1.2 Global Pharmaceutical Intermediates Forecasted Sales Quantity by Type (2025-2030)
4.1.3 Global Pharmaceutical Intermediates Sales Quantity Market Share by Type (2019-2030)
4.2 Global Pharmaceutical Intermediates Revenue by Type
4.2.1 Global Pharmaceutical Intermediates Historical Revenue by Type (2019-2024)
4.2.2 Global Pharmaceutical Intermediates Forecasted Revenue by Type (2025-2030)
4.2.3 Global Pharmaceutical Intermediates Revenue Market Share by Type (2019-2030)
4.3 Global Pharmaceutical Intermediates Price by Type
4.3.1 Global Pharmaceutical Intermediates Price by Type (2019-2024)
4.3.2 Global Pharmaceutical Intermediates Price Forecast by Type (2025-2030)
5 Market Size by Application
5.1 Global Pharmaceutical Intermediates Sales Quantity by Application
5.1.1 Global Pharmaceutical Intermediates Historical Sales Quantity by Application (2019-2024)
5.1.2 Global Pharmaceutical Intermediates Forecasted Sales Quantity by Application (2025-2030)
5.1.3 Global Pharmaceutical Intermediates Sales Quantity Market Share by Application (2019-2030)
5.2 Global Pharmaceutical Intermediates Revenue by Application
5.2.1 Global Pharmaceutical Intermediates Historical Revenue by Application (2019-2024)
5.2.2 Global Pharmaceutical Intermediates Forecasted Revenue by Application (2025-2030)
5.2.3 Global Pharmaceutical Intermediates Revenue Market Share by Application (2019-2030)
5.3 Global Pharmaceutical Intermediates Price by Application
5.3.1 Global Pharmaceutical Intermediates Price by Application (2019-2024)
5.3.2 Global Pharmaceutical Intermediates Price Forecast by Application (2025-2030)
6 North America
6.1 North America Pharmaceutical Intermediates Sales by Company
6.1.1 North America Pharmaceutical Intermediates Revenue by Company (2019-2024)
6.1.2 North America Pharmaceutical Intermediates Sales Quantity by Company (2019-2024)
6.2 North America Pharmaceutical Intermediates Market Size by Type
6.2.1 North America Pharmaceutical Intermediates Sales Quantity by Type (2019-2030)
6.2.2 North America Pharmaceutical Intermediates Revenue by Type (2019-2030)
6.3 North America Pharmaceutical Intermediates Market Size by Application
6.3.1 North America Pharmaceutical Intermediates Sales Quantity by Application (2019-2030)
6.3.2 North America Pharmaceutical Intermediates Revenue by Application (2019-2030)
6.4 North America Pharmaceutical Intermediates Market Size by Country
6.4.1 North America Pharmaceutical Intermediates Revenue by Country: 2019 VS 2023 VS 2030
6.4.2 North America Pharmaceutical Intermediates Revenue by Country (2019-2030)
6.4.3 North America Pharmaceutical Intermediates Sales Quantity by Country (2019-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Pharmaceutical Intermediates Sales by Company
7.1.1 Europe Pharmaceutical Intermediates Sales Quantity by Company (2019-2024)
7.1.2 Europe Pharmaceutical Intermediates Revenue by Company (2019-2024)
7.2 Europe Pharmaceutical Intermediates Market Size by Type
7.2.1 Europe Pharmaceutical Intermediates Sales Quantity by Type (2019-2030)
7.2.2 Europe Pharmaceutical Intermediates Revenue by Type (2019-2030)
7.3 Europe Pharmaceutical Intermediates Market Size by Application
7.3.1 Europe Pharmaceutical Intermediates Sales Quantity by Application (2019-2030)
7.3.2 Europe Pharmaceutical Intermediates Revenue by Application (2019-2030)
7.4 Europe Pharmaceutical Intermediates Market Size by Country
7.4.1 Europe Pharmaceutical Intermediates Revenue by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Pharmaceutical Intermediates Revenue by Country (2019-2030)
7.4.3 Europe Pharmaceutical Intermediates Sales Quantity by Country (2019-2030)
7.4.4 Germany
7.4.5 France
7.4.6 U.K.
7.4.7 Italy
7.4.8 Russia
8 China
8.1 China Pharmaceutical Intermediates Sales by Company
8.1.1 China Pharmaceutical Intermediates Sales Quantity by Company (2019-2024)
8.1.2 China Pharmaceutical Intermediates Revenue by Company (2019-2024)
8.2 China Pharmaceutical Intermediates Market Size by Type
8.2.1 China Pharmaceutical Intermediates Sales Quantity by Type (2019-2030)
8.2.2 China Pharmaceutical Intermediates Revenue by Type (2019-2030)
8.3 China Pharmaceutical Intermediates Market Size by Application
8.3.1 China Pharmaceutical Intermediates Sales Quantity by Application (2019-2030)
8.3.2 China Pharmaceutical Intermediates Revenue by Application (2019-2030)
9 APAC (excluding China)
9.1 APAC Pharmaceutical Intermediates Sales by Company
9.1.1 APAC Pharmaceutical Intermediates Sales Quantity by Company (2019-2024)
9.1.2 APAC Pharmaceutical Intermediates Revenue by Company (2019-2024)
9.2 APAC Pharmaceutical Intermediates Market Size by Type
9.2.1 APAC Pharmaceutical Intermediates Sales Quantity by Type (2019-2030)
9.2.2 APAC Pharmaceutical Intermediates Revenue by Type (2019-2030)
9.3 APAC Pharmaceutical Intermediates Market Size by Application
9.3.1 APAC Pharmaceutical Intermediates Sales Quantity by Application (2019-2030)
9.3.2 APAC Pharmaceutical Intermediates Revenue by Application (2019-2030)
9.4 APAC Pharmaceutical Intermediates Market Size by Region
9.4.1 APAC Pharmaceutical Intermediates Revenue by Region: 2019 VS 2023 VS 2030
9.4.2 APAC Pharmaceutical Intermediates Revenue by Region (2019-2030)
9.4.3 APAC Pharmaceutical Intermediates Sales Quantity by Region (2019-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Pharmaceutical Intermediates Sales by Company
10.1.1 Middle East, Africa and Latin America Pharmaceutical Intermediates Sales Quantity by Company (2019-2024)
10.1.2 Middle East, Africa and Latin America Pharmaceutical Intermediates Revenue by Company (2019-2024)
10.2 Middle East, Africa and Latin America Pharmaceutical Intermediates Market Size by Type
10.2.1 Middle East, Africa and Latin America Pharmaceutical Intermediates Sales Quantity by Type (2019-2030)
10.2.2 Middle East, Africa and Latin America Pharmaceutical Intermediates Revenue by Type (2019-2030)
10.3 Middle East, Africa and Latin America Pharmaceutical Intermediates Market Size by Application
10.3.1 Middle East, Africa and Latin America Pharmaceutical Intermediates Sales Quantity by Application (2019-2030)
10.3.2 Middle East, Africa and Latin America Pharmaceutical Intermediates Revenue by Application (2019-2030)
10.4 Middle East, Africa and Latin America Pharmaceutical Intermediates Market Size by Country
10.4.1 Middle East, Africa and Latin America Pharmaceutical Intermediates Revenue by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa and Latin America Pharmaceutical Intermediates Revenue by Country (2019-2030)
10.4.3 Middle East, Africa and Latin America Pharmaceutical Intermediates Sales Quantity by Country (2019-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Israel
10.4.8 GCC Countries
11 Company Profiles
11.1 Lonza
11.1.1 Lonza Company Information
11.1.2 Lonza Overview
11.1.3 Lonza Pharmaceutical Intermediates Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2019-2024)
11.1.4 Lonza Pharmaceutical Intermediates Products and Services
11.1.5 Lonza Pharmaceutical Intermediates SWOT Analysis
11.1.6 Lonza Recent Developments
11.2 Catalent
11.2.1 Catalent Company Information
11.2.2 Catalent Overview
11.2.3 Catalent Pharmaceutical Intermediates Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2019-2024)
11.2.4 Catalent Pharmaceutical Intermediates Products and Services
11.2.5 Catalent Pharmaceutical Intermediates SWOT Analysis
11.2.6 Catalent Recent Developments
11.3 Patheon
11.3.1 Patheon Company Information
11.3.2 Patheon Overview
11.3.3 Patheon Pharmaceutical Intermediates Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2019-2024)
11.3.4 Patheon Pharmaceutical Intermediates Products and Services
11.3.5 Patheon Pharmaceutical Intermediates SWOT Analysis
11.3.6 Patheon Recent Developments
11.4 Jubilant
11.4.1 Jubilant Company Information
11.4.2 Jubilant Overview
11.4.3 Jubilant Pharmaceutical Intermediates Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2019-2024)
11.4.4 Jubilant Pharmaceutical Intermediates Products and Services
11.4.5 Jubilant Pharmaceutical Intermediates SWOT Analysis
11.4.6 Jubilant Recent Developments
11.5 Granules
11.5.1 Granules Company Information
11.5.2 Granules Overview
11.5.3 Granules Pharmaceutical Intermediates Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2019-2024)
11.5.4 Granules Pharmaceutical Intermediates Products and Services
11.5.5 Granules Pharmaceutical Intermediates SWOT Analysis
11.5.6 Granules Recent Developments
11.6 Ganesh
11.6.1 Ganesh Company Information
11.6.2 Ganesh Overview
11.6.3 Ganesh Pharmaceutical Intermediates Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2019-2024)
11.6.4 Ganesh Pharmaceutical Intermediates Products and Services
11.6.5 Ganesh Pharmaceutical Intermediates SWOT Analysis
11.6.6 Ganesh Recent Developments
11.7 Chemcon
11.7.1 Chemcon Company Information
11.7.2 Chemcon Overview
11.7.3 Chemcon Pharmaceutical Intermediates Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2019-2024)
11.7.4 Chemcon Pharmaceutical Intermediates Products and Services
11.7.5 Chemcon Pharmaceutical Intermediates SWOT Analysis
11.7.6 Chemcon Recent Developments
11.8 BASF
11.8.1 BASF Company Information
11.8.2 BASF Overview
11.8.3 BASF Pharmaceutical Intermediates Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2019-2024)
11.8.4 BASF Pharmaceutical Intermediates Products and Services
11.8.5 BASF Pharmaceutical Intermediates SWOT Analysis
11.8.6 BASF Recent Developments
11.9 Porton
11.9.1 Porton Company Information
11.9.2 Porton Overview
11.9.3 Porton Pharmaceutical Intermediates Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2019-2024)
11.9.4 Porton Pharmaceutical Intermediates Products and Services
11.9.5 Porton Pharmaceutical Intermediates SWOT Analysis
11.9.6 Porton Recent Developments
11.10 Lianhetech
11.10.1 Lianhetech Company Information
11.10.2 Lianhetech Overview
11.10.3 Lianhetech Pharmaceutical Intermediates Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2019-2024)
11.10.4 Lianhetech Pharmaceutical Intermediates Products and Services
11.10.5 Lianhetech Pharmaceutical Intermediates SWOT Analysis
11.10.6 Lianhetech Recent Developments
11.11 ABA Chem
11.11.1 ABA Chem Company Information
11.11.2 ABA Chem Overview
11.11.3 ABA Chem Pharmaceutical Intermediates Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2019-2024)
11.11.4 ABA Chem Pharmaceutical Intermediates Products and Services
11.11.5 ABA Chem Recent Developments
11.12 Tianma
11.12.1 Tianma Company Information
11.12.2 Tianma Overview
11.12.3 Tianma Pharmaceutical Intermediates Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2019-2024)
11.12.4 Tianma Pharmaceutical Intermediates Products and Services
11.12.5 Tianma Recent Developments
11.13 Jiujiujiu
11.13.1 Jiujiujiu Company Information
11.13.2 Jiujiujiu Overview
11.13.3 Jiujiujiu Pharmaceutical Intermediates Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2019-2024)
11.13.4 Jiujiujiu Pharmaceutical Intermediates Products and Services
11.13.5 Jiujiujiu Recent Developments
11.14 Alpha
11.14.1 Alpha Company Information
11.14.2 Alpha Overview
11.14.3 Alpha Pharmaceutical Intermediates Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2019-2024)
11.14.4 Alpha Pharmaceutical Intermediates Products and Services
11.14.5 Alpha Recent Developments
11.15 Jiuzhou
11.15.1 Jiuzhou Company Information
11.15.2 Jiuzhou Overview
11.15.3 Jiuzhou Pharmaceutical Intermediates Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2019-2024)
11.15.4 Jiuzhou Pharmaceutical Intermediates Products and Services
11.15.5 Jiuzhou Recent Developments
11.16 Yongtai
11.16.1 Yongtai Company Information
11.16.2 Yongtai Overview
11.16.3 Yongtai Pharmaceutical Intermediates Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2019-2024)
11.16.4 Yongtai Pharmaceutical Intermediates Products and Services
11.16.5 Yongtai Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Pharmaceutical Intermediates Value Chain Analysis
12.2 Pharmaceutical Intermediates Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Pharmaceutical Intermediates Production Mode & Process
12.4 Pharmaceutical Intermediates Sales and Marketing
12.4.1 Pharmaceutical Intermediates Sales Channels
12.4.2 Pharmaceutical Intermediates Distributors
12.5 Pharmaceutical Intermediates Customers
13 Market Dynamics
13.1 Pharmaceutical Intermediates Industry Trends
13.2 Pharmaceutical Intermediates Market Drivers
13.3 Pharmaceutical Intermediates Market Challenges
13.4 Pharmaceutical Intermediates Market Restraints
14 Key Findings
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Global Pharmaceutical Intermediates Market Size Growth Rate (CAGR) by Type, 2019 VS 2023 VS 2030 (US$ Million)
Table 2. Major Manufacturers of GMP
Table 3. Major Manufacturers of Non-GMP
Table 4. Global Pharmaceutical Intermediates Market Size Growth Rate (CAGR) by Application, 2019 VS 2023 VS 2030 (US$ Million)
Table 5. Global Pharmaceutical Intermediates Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 6. Global Pharmaceutical Intermediates Revenue by Region (2019-2024) & (US$ Million)
Table 7. Global Pharmaceutical Intermediates Revenue Market Share by Region (2019-2024)
Table 8. Global Pharmaceutical Intermediates Revenue by Region (2025-2030) & (US$ Million)
Table 9. Global Pharmaceutical Intermediates Revenue Market Share by Region (2025-2030)
Table 10. Global Pharmaceutical Intermediates Sales Quantity by Region: 2019 VS 2023 VS 2030 (K MT)
Table 11. Global Pharmaceutical Intermediates Sales by Region (2019-2024) & (K MT)
Table 12. Global Pharmaceutical Intermediates Sales Market Share by Region (2019-2024)
Table 13. Global Pharmaceutical Intermediates Sales by Region (2025-2030) & (K MT)
Table 14. Global Pharmaceutical Intermediates Sales Market Share by Region (2025-2030)
Table 15. Global Pharmaceutical Intermediates Sales Quantity by Manufacturers (2019-2024) & (K MT)
Table 16. Global Pharmaceutical Intermediates Sales Quantity Share by Manufacturers (2019-2024)
Table 17. Global Pharmaceutical Intermediates Revenue by Manufacturers (2019-2024) & (US$ Million)
Table 18. Global Pharmaceutical Intermediates Revenue Share by Manufacturers (2019-2024)
Table 19. Global Pharmaceutical Intermediates Price by Manufacturers 2019-2024 (USD/MT)
Table 20. Global Key Players of Pharmaceutical Intermediates, Industry Ranking, 2022 VS 2023
Table 21. Global Pharmaceutical Intermediates Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Pharmaceutical Intermediates by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pharmaceutical Intermediates as of 2023)
Table 23. Global Key Manufacturers of Pharmaceutical Intermediates, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Pharmaceutical Intermediates, Product Offered and Application
Table 25. Global Key Manufacturers of Pharmaceutical Intermediates, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Pharmaceutical Intermediates Sales Quantity by Type (2019-2024) & (K MT)
Table 28. Global Pharmaceutical Intermediates Sales Quantity by Type (2025-2030) & (K MT)
Table 29. Global Pharmaceutical Intermediates Sales Quantity Share by Type (2019-2024)
Table 30. Global Pharmaceutical Intermediates Sales Quantity Share by Type (2025-2030)
Table 31. Global Pharmaceutical Intermediates Revenue by Type (2019-2024) & (US$ Million)
Table 32. Global Pharmaceutical Intermediates Revenue by Type (2025-2030) & (US$ Million)
Table 33. Global Pharmaceutical Intermediates Revenue Share by Type (2019-2024)
Table 34. Global Pharmaceutical Intermediates Revenue Share by Type (2025-2030)
Table 35. Pharmaceutical Intermediates Price by Type (2019-2024) & (USD/MT)
Table 36. Global Pharmaceutical Intermediates Price Forecast by Type (2025-2030) & (USD/MT)
Table 37. Global Pharmaceutical Intermediates Sales Quantity by Application (2019-2024) & (K MT)
Table 38. Global Pharmaceutical Intermediates Sales Quantity by Application (2025-2030) & (K MT)
Table 39. Global Pharmaceutical Intermediates Sales Quantity Share by Application (2019-2024)
Table 40. Global Pharmaceutical Intermediates Sales Quantity Share by Application (2025-2030)
Table 41. Global Pharmaceutical Intermediates Revenue by Application (2019-2024) & (US$ Million)
Table 42. Global Pharmaceutical Intermediates Revenue by Application (2025-2030) & (US$ Million)
Table 43. Global Pharmaceutical Intermediates Revenue Share by Application (2019-2024)
Table 44. Global Pharmaceutical Intermediates Revenue Share by Application (2025-2030)
Table 45. Pharmaceutical Intermediates Price by Application (2019-2024) & (USD/MT)
Table 46. Global Pharmaceutical Intermediates Price Forecast by Application (2025-2030) & (USD/MT)
Table 47. North America Pharmaceutical Intermediates Revenue by Company (2019-2024) & (US$ Million)
Table 48. North America Pharmaceutical Intermediates Sales Quantity by Company (2019-2024) & (K MT)
Table 49. North America Pharmaceutical Intermediates Sales Quantity by Type (2019-2024) & (K MT)
Table 50. North America Pharmaceutical Intermediates Sales Quantity by Type (2025-2030) & (K MT)
Table 51. North America Pharmaceutical Intermediates Revenue by Type (2019-2024) & (US$ Million)
Table 52. North America Pharmaceutical Intermediates Revenue by Type (2025-2030) & (US$ Million)
Table 53. North America Pharmaceutical Intermediates Sales Quantity by Application (2019-2024) & (K MT)
Table 54. North America Pharmaceutical Intermediates Sales Quantity by Application (2025-2030) & (K MT)
Table 55. North America Pharmaceutical Intermediates Revenue by Application (2019-2024) & (US$ Million)
Table 56. North America Pharmaceutical Intermediates Revenue by Application (2025-2030) & (US$ Million)
Table 57. North America Pharmaceutical Intermediates Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 58. North America Pharmaceutical Intermediates Revenue by Country (2019-2024) & (US$ Million)
Table 59. North America Pharmaceutical Intermediates Revenue by Country (2025-2030) & (US$ Million)
Table 60. North America Pharmaceutical Intermediates Sales Quantity by Country (2019-2024) & (K MT)
Table 61. North America Pharmaceutical Intermediates Sales Quantity by Country (2025-2030) & (K MT)
Table 62. Europe Pharmaceutical Intermediates Sales Quantity by Company (2019-2024) & (K MT)
Table 63. Europe Pharmaceutical Intermediates Revenue by Company (2019-2024) & (US$ Million)
Table 64. Europe Pharmaceutical Intermediates Sales Quantity by Type (2019-2024) & (K MT)
Table 65. Europe Pharmaceutical Intermediates Sales Quantity by Type (2025-2030) & (K MT)
Table 66. Europe Pharmaceutical Intermediates Revenue by Type (2019-2024) & (US$ Million)
Table 67. Europe Pharmaceutical Intermediates Revenue by Type (2025-2030) & (US$ Million)
Table 68. Europe Pharmaceutical Intermediates Sales Quantity by Application (2019-2024) & (K MT)
Table 69. Europe Pharmaceutical Intermediates Sales Quantity by Application (2025-2030) & (K MT)
Table 70. Europe Pharmaceutical Intermediates Revenue by Application (2019-2024) & (US$ Million)
Table 71. Europe Pharmaceutical Intermediates Revenue by Application (2025-2030) & (US$ Million)
Table 72. Europe Pharmaceutical Intermediates Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 73. Europe Pharmaceutical Intermediates Revenue by Country (2019-2024) & (US$ Million)
Table 74. Europe Pharmaceutical Intermediates Revenue by Country (2025-2030) & (US$ Million)
Table 75. Europe Pharmaceutical Intermediates Sales Quantity by Country (2019-2024) & (K MT)
Table 76. Europe Pharmaceutical Intermediates Sales Quantity by Country (2025-2030) & (K MT)
Table 77. China Pharmaceutical Intermediates Sales Quantity by Company (2019-2024) & (K MT)
Table 78. China Pharmaceutical Intermediates Revenue by Company (2019-2024) & (US$ Million)
Table 79. China Pharmaceutical Intermediates Sales Quantity by Type (2019-2024) & (K MT)
Table 80. China Pharmaceutical Intermediates Sales Quantity by Type (2025-2030) & (K MT)
Table 81. China Pharmaceutical Intermediates Revenue by Type (2019-2024) & (US$ Million)
Table 82. China Pharmaceutical Intermediates Revenue by Type (2025-2030) & (US$ Million)
Table 83. China Pharmaceutical Intermediates Sales Quantity by Application (2019-2024) & (K MT)
Table 84. China Pharmaceutical Intermediates Sales Quantity by Application (2025-2030) & (K MT)
Table 85. China Pharmaceutical Intermediates Revenue by Application (2019-2024) & (US$ Million)
Table 86. China Pharmaceutical Intermediates Revenue by Application (2025-2030) & (US$ Million)
Table 87. APAC Pharmaceutical Intermediates Sales Quantity by Company (2019-2024) & (K MT)
Table 88. APAC Pharmaceutical Intermediates Revenue by Company (2019-2024) & (US$ Million)
Table 89. APAC Pharmaceutical Intermediates Sales Quantity by Type (2019-2024) & (K MT)
Table 90. APAC Pharmaceutical Intermediates Sales Quantity by Type (2025-2030) & (K MT)
Table 91. APAC Pharmaceutical Intermediates Revenue by Type (2019-2024) & (US$ Million)
Table 92. APAC Pharmaceutical Intermediates Revenue by Type (2025-2030) & (US$ Million)
Table 93. APAC Pharmaceutical Intermediates Sales Quantity by Application (2019-2024) & (K MT)
Table 94. APAC Pharmaceutical Intermediates Sales Quantity by Application (2025-2030) & (K MT)
Table 95. APAC Pharmaceutical Intermediates Revenue by Application (2019-2024) & (US$ Million)
Table 96. APAC Pharmaceutical Intermediates Revenue by Application (2025-2030) & (US$ Million)
Table 97. APAC Pharmaceutical Intermediates Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 98. APAC Pharmaceutical Intermediates Revenue by Region (2019-2024) & (US$ Million)
Table 99. APAC Pharmaceutical Intermediates Revenue by Region (2025-2030) & (US$ Million)
Table 100. APAC Pharmaceutical Intermediates Sales Quantity by Region (2019-2024) & (K MT)
Table 101. APAC Pharmaceutical Intermediates Sales Quantity by Region (2025-2030) & (K MT)
Table 102. Middle East, Africa and Latin America Pharmaceutical Intermediates Sales Quantity by Company (2019-2024) & (K MT)
Table 103. Middle East, Africa and Latin America Pharmaceutical Intermediates Revenue by Company (2019-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Pharmaceutical Intermediates Sales Quantity by Type (2019-2024) & (K MT)
Table 105. Middle East, Africa and Latin America Pharmaceutical Intermediates Sales Quantity by Type (2025-2030) & (K MT)
Table 106. Middle East, Africa and Latin America Pharmaceutical Intermediates Revenue by Type (2019-2024) & (US$ Million)
Table 107. Middle East, Africa and Latin America Pharmaceutical Intermediates Revenue by Type (2025-2030) & (US$ Million)
Table 108. Middle East, Africa and Latin America Pharmaceutical Intermediates Sales Quantity by Application (2019-2024) & (K MT)
Table 109. Middle East, Africa and Latin America Pharmaceutical Intermediates Sales Quantity by Application (2025-2030) & (K MT)
Table 110. Middle East, Africa and Latin America Pharmaceutical Intermediates Revenue by Application (2019-2024) & (US$ Million)
Table 111. Middle East, Africa and Latin America Pharmaceutical Intermediates Revenue by Application (2025-2030) & (US$ Million)
Table 112. Middle East, Africa and Latin America Pharmaceutical Intermediates Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 113. Middle East, Africa and Latin America Pharmaceutical Intermediates Revenue by Country (2019-2024) & (US$ Million)
Table 114. Middle East, Africa and Latin America Pharmaceutical Intermediates Revenue by Country (2025-2030) & (US$ Million)
Table 115. Middle East, Africa and Latin America Pharmaceutical Intermediates Sales Quantity by Country (2019-2024) & (K MT)
Table 116. Middle East, Africa and Latin America Pharmaceutical Intermediates Sales Quantity by Country (2025-2030) & (K MT)
Table 117. Lonza Company Information
Table 118. Lonza Description and Overview
Table 119. Lonza Pharmaceutical Intermediates Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2019-2024)
Table 120. Lonza Pharmaceutical Intermediates Product and Services
Table 121. Lonza Pharmaceutical Intermediates SWOT Analysis
Table 122. Lonza Recent Developments
Table 123. Catalent Company Information
Table 124. Catalent Description and Overview
Table 125. Catalent Pharmaceutical Intermediates Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2019-2024)
Table 126. Catalent Pharmaceutical Intermediates Product and Services
Table 127. Catalent Pharmaceutical Intermediates SWOT Analysis
Table 128. Catalent Recent Developments
Table 129. Patheon Company Information
Table 130. Patheon Description and Overview
Table 131. Patheon Pharmaceutical Intermediates Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2019-2024)
Table 132. Patheon Pharmaceutical Intermediates Product and Services
Table 133. Patheon Pharmaceutical Intermediates SWOT Analysis
Table 134. Patheon Recent Developments
Table 135. Jubilant Company Information
Table 136. Jubilant Description and Overview
Table 137. Jubilant Pharmaceutical Intermediates Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2019-2024)
Table 138. Jubilant Pharmaceutical Intermediates Product and Services
Table 139. Jubilant Pharmaceutical Intermediates SWOT Analysis
Table 140. Jubilant Recent Developments
Table 141. Granules Company Information
Table 142. Granules Description and Overview
Table 143. Granules Pharmaceutical Intermediates Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2019-2024)
Table 144. Granules Pharmaceutical Intermediates Product and Services
Table 145. Granules Pharmaceutical Intermediates SWOT Analysis
Table 146. Granules Recent Developments
Table 147. Ganesh Company Information
Table 148. Ganesh Description and Overview
Table 149. Ganesh Pharmaceutical Intermediates Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2019-2024)
Table 150. Ganesh Pharmaceutical Intermediates Product and Services
Table 151. Ganesh Pharmaceutical Intermediates SWOT Analysis
Table 152. Ganesh Recent Developments
Table 153. Chemcon Company Information
Table 154. Chemcon Description and Overview
Table 155. Chemcon Pharmaceutical Intermediates Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2019-2024)
Table 156. Chemcon Pharmaceutical Intermediates Product and Services
Table 157. Chemcon Pharmaceutical Intermediates SWOT Analysis
Table 158. Chemcon Recent Developments
Table 159. BASF Company Information
Table 160. BASF Description and Overview
Table 161. BASF Pharmaceutical Intermediates Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2019-2024)
Table 162. BASF Pharmaceutical Intermediates Product and Services
Table 163. BASF Pharmaceutical Intermediates SWOT Analysis
Table 164. BASF Recent Developments
Table 165. Porton Company Information
Table 166. Porton Description and Overview
Table 167. Porton Pharmaceutical Intermediates Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2019-2024)
Table 168. Porton Pharmaceutical Intermediates Product and Services
Table 169. Porton Pharmaceutical Intermediates SWOT Analysis
Table 170. Porton Recent Developments
Table 171. Lianhetech Company Information
Table 172. Lianhetech Description and Overview
Table 173. Lianhetech Pharmaceutical Intermediates Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2019-2024)
Table 174. Lianhetech Pharmaceutical Intermediates Product and Services
Table 175. Lianhetech Pharmaceutical Intermediates SWOT Analysis
Table 176. Lianhetech Recent Developments
Table 177. ABA Chem Company Information
Table 178. ABA Chem Description and Overview
Table 179. ABA Chem Pharmaceutical Intermediates Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2019-2024)
Table 180. ABA Chem Pharmaceutical Intermediates Product and Services
Table 181. ABA Chem Recent Developments
Table 182. Tianma Company Information
Table 183. Tianma Description and Overview
Table 184. Tianma Pharmaceutical Intermediates Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2019-2024)
Table 185. Tianma Pharmaceutical Intermediates Product and Services
Table 186. Tianma Recent Developments
Table 187. Jiujiujiu Company Information
Table 188. Jiujiujiu Description and Overview
Table 189. Jiujiujiu Pharmaceutical Intermediates Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2019-2024)
Table 190. Jiujiujiu Pharmaceutical Intermediates Product and Services
Table 191. Jiujiujiu Recent Developments
Table 192. Alpha Company Information
Table 193. Alpha Description and Overview
Table 194. Alpha Pharmaceutical Intermediates Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2019-2024)
Table 195. Alpha Pharmaceutical Intermediates Product and Services
Table 196. Alpha Recent Developments
Table 197. Jiuzhou Company Information
Table 198. Jiuzhou Description and Overview
Table 199. Jiuzhou Pharmaceutical Intermediates Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2019-2024)
Table 200. Jiuzhou Pharmaceutical Intermediates Product and Services
Table 201. Jiuzhou Recent Developments
Table 202. Yongtai Company Information
Table 203. Yongtai Description and Overview
Table 204. Yongtai Pharmaceutical Intermediates Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2019-2024)
Table 205. Yongtai Pharmaceutical Intermediates Product and Services
Table 206. Yongtai Recent Developments
Table 207. Key Raw Materials Lists
Table 208. Raw Materials Key Suppliers Lists
Table 209. Pharmaceutical Intermediates Distributors List
Table 210. Pharmaceutical Intermediates Customers List
Table 211. Pharmaceutical Intermediates Market Trends
Table 212. Pharmaceutical Intermediates Market Drivers
Table 213. Pharmaceutical Intermediates Market Challenges
Table 214. Pharmaceutical Intermediates Market Restraints
Table 215. Research Programs/Design for This Report
Table 216. Key Data Information from Secondary Sources
Table 217. Key Data Information from Primary Sources
List of Figures
Figure 1. Pharmaceutical Intermediates Product Picture
Figure 2. Global Pharmaceutical Intermediates Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Pharmaceutical Intermediates Market Share by Type in 2023 & 2030
Figure 4. GMP Product Picture
Figure 5. Non-GMP Product Picture
Figure 6. Global Pharmaceutical Intermediates Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Figure 7. Global Pharmaceutical Intermediates Market Share by Application in 2023 & 2030
Figure 8. Antibiotics
Figure 9. Antipyretic Analgesics
Figure 10. Vitamins
Figure 11. Others
Figure 12. Pharmaceutical Intermediates Report Years Considered
Figure 13. Global Pharmaceutical Intermediates Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Pharmaceutical Intermediates Revenue 2019-2030 (US$ Million)
Figure 15. Global Pharmaceutical Intermediates Revenue Market Share by Region in Percentage: 2023 Versus 2030
Figure 16. Global Pharmaceutical Intermediates Sales Quantity 2019-2030 (K MT)
Figure 17. Global Pharmaceutical Intermediates Sales Quantity Market Share by Region (2019-2024)
Figure 18. Global Pharmaceutical Intermediates Sales Quantity Market Share by Region (2025-2030)
Figure 19. North America Pharmaceutical Intermediates Sales Quantity YoY (2019-2030) & (K MT)
Figure 20. North America Pharmaceutical Intermediates Revenue YoY (2019-2030) & (US$ Million)
Figure 21. Europe Pharmaceutical Intermediates Sales Quantity YoY (2019-2030) & (K MT)
Figure 22. Europe Pharmaceutical Intermediates Revenue YoY (2019-2030) & (US$ Million)
Figure 23. China Pharmaceutical Intermediates Sales Quantity YoY (2019-2030) & (K MT)
Figure 24. China Pharmaceutical Intermediates Revenue YoY (2019-2030) & (US$ Million)
Figure 25. APAC Pharmaceutical Intermediates Sales Quantity YoY (2019-2030) & (K MT)
Figure 26. APAC Pharmaceutical Intermediates Revenue YoY (2019-2030) & (US$ Million)
Figure 27. Middle East, Africa and Latin America Pharmaceutical Intermediates Sales Quantity YoY (2019-2030) & (K MT)
Figure 28. Middle East, Africa and Latin America Pharmaceutical Intermediates Revenue YoY (2019-2030) & (US$ Million)
Figure 29. The Top 10 and Top 5 Players Market Share by Pharmaceutical Intermediates Sales Quantity in 2023
Figure 30. The Top 10 and Top 5 Players Market Share by Pharmaceutical Intermediates Revenue in 2023
Figure 31. Pharmaceutical Intermediates Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 32. Global Pharmaceutical Intermediates Sales Quantity Market Share by Type (2019-2030)
Figure 33. Global Pharmaceutical Intermediates Revenue Market Share by Type (2019-2030)
Figure 34. Global Pharmaceutical Intermediates Sales Quantity Market Share by Application (2019-2030)
Figure 35. Global Pharmaceutical Intermediates Revenue Market Share by Application (2019-2030)
Figure 36. North America Pharmaceutical Intermediates Revenue Market Share by Company in 2023
Figure 37. North America Pharmaceutical Intermediates Sales Quantity Market Share by Company in 2023
Figure 38. North America Pharmaceutical Intermediates Sales Quantity Market Share by Type (2019-2030)
Figure 39. North America Pharmaceutical Intermediates Revenue Market Share by Type (2019-2030)
Figure 40. North America Pharmaceutical Intermediates Sales Quantity Market Share by Application (2019-2030)
Figure 41. North America Pharmaceutical Intermediates Revenue Market Share by Application (2019-2030)
Figure 42. North America Pharmaceutical Intermediates Revenue Share by Country (2019-2030)
Figure 43. North America Pharmaceutical Intermediates Sales Quantity Share by Country (2019-2030)
Figure 44. U.S. Pharmaceutical Intermediates Revenue (2019-2030) & (US$ Million)
Figure 45. Canada Pharmaceutical Intermediates Revenue (2019-2030) & (US$ Million)
Figure 46. Europe Pharmaceutical Intermediates Sales Quantity Market Share by Company in 2023
Figure 47. Europe Pharmaceutical Intermediates Revenue Market Share by Company in 2023
Figure 48. Europe Pharmaceutical Intermediates Sales Quantity Market Share by Type (2019-2030)
Figure 49. Europe Pharmaceutical Intermediates Revenue Market Share by Type (2019-2030)
Figure 50. Europe Pharmaceutical Intermediates Sales Quantity Market Share by Application (2019-2030)
Figure 51. Europe Pharmaceutical Intermediates Revenue Market Share by Application (2019-2030)
Figure 52. Europe Pharmaceutical Intermediates Revenue Share by Country (2019-2030)
Figure 53. Europe Pharmaceutical Intermediates Sales Quantity Share by Country (2019-2030)
Figure 54. Germany Pharmaceutical Intermediates Revenue (2019-2030) & (US$ Million)
Figure 55. France Pharmaceutical Intermediates Revenue (2019-2030) & (US$ Million)
Figure 56. U.K. Pharmaceutical Intermediates Revenue (2019-2030) & (US$ Million)
Figure 57. Italy Pharmaceutical Intermediates Revenue (2019-2030) & (US$ Million)
Figure 58. Russia Pharmaceutical Intermediates Revenue (2019-2030) & (US$ Million)
Figure 59. China Pharmaceutical Intermediates Sales Quantity Market Share by Company in 2023
Figure 60. China Pharmaceutical Intermediates Revenue Market Share by Company in 2023
Figure 61. China Pharmaceutical Intermediates Sales Quantity Market Share by Type (2019-2030)
Figure 62. China Pharmaceutical Intermediates Revenue Market Share by Type (2019-2030)
Figure 63. China Pharmaceutical Intermediates Sales Quantity Market Share by Application (2019-2030)
Figure 64. China Pharmaceutical Intermediates Revenue Market Share by Application (2019-2030)
Figure 65. APAC Pharmaceutical Intermediates Sales Quantity Market Share by Company in 2023
Figure 66. APAC Pharmaceutical Intermediates Revenue Market Share by Company in 2023
Figure 67. APAC Pharmaceutical Intermediates Sales Quantity Market Share by Type (2019-2030)
Figure 68. APAC Pharmaceutical Intermediates Revenue Market Share by Type (2019-2030)
Figure 69. APAC Pharmaceutical Intermediates Sales Quantity Market Share by Application (2019-2030)
Figure 70. APAC Pharmaceutical Intermediates Revenue Market Share by Application (2019-2030)
Figure 71. APAC Pharmaceutical Intermediates Revenue Share by Region (2019-2030)
Figure 72. APAC Pharmaceutical Intermediates Sales Quantity Share by Region (2019-2030)
Figure 73. Japan Pharmaceutical Intermediates Revenue (2019-2030) & (US$ Million)
Figure 74. South Korea Pharmaceutical Intermediates Revenue (2019-2030) & (US$ Million)
Figure 75. China Taiwan Pharmaceutical Intermediates Revenue (2019-2030) & (US$ Million)
Figure 76. Southeast Asia Pharmaceutical Intermediates Revenue (2019-2030) & (US$ Million)
Figure 77. India Pharmaceutical Intermediates Revenue (2019-2030) & (US$ Million)
Figure 78. Middle East, Africa and Latin America Pharmaceutical Intermediates Sales Quantity Market Share by Company in 2023
Figure 79. Middle East, Africa and Latin America Pharmaceutical Intermediates Revenue Market Share by Company in 2023
Figure 80. Middle East, Africa and Latin America Pharmaceutical Intermediates Sales Quantity Market Share by Type (2019-2030)
Figure 81. Middle East, Africa and Latin America Pharmaceutical Intermediates Revenue Market Share by Type (2019-2030)
Figure 82. Middle East, Africa and Latin America Pharmaceutical Intermediates Sales Quantity Market Share by Application (2019-2030)
Figure 83. Middle East, Africa and Latin America Pharmaceutical Intermediates Revenue Market Share by Application (2019-2030)
Figure 84. Middle East, Africa and Latin America Pharmaceutical Intermediates Sales Quantity Share by Country (2019-2030)
Figure 85. Middle East, Africa and Latin America Pharmaceutical Intermediates Revenue Share by Country (2019-2030)
Figure 86. Brazil Pharmaceutical Intermediates Revenue (2019-2030) & (US$ Million)
Figure 87. Mexico Pharmaceutical Intermediates Revenue (2019-2030) & (US$ Million)
Figure 88. Turkey Pharmaceutical Intermediates Revenue (2019-2030) & (US$ Million)
Figure 89. Israel Pharmaceutical Intermediates Revenue (2019-2030) & (US$ Million)
Figure 90. GCC Countries Pharmaceutical Intermediates Revenue (2019-2030) & (US$ Million)
Figure 91. Pharmaceutical Intermediates Value Chain
Figure 92. Pharmaceutical Intermediates Production Process
Figure 93. Channels of Distribution (Direct Vs Distribution)
Figure 94. Distributors Profiles
Figure 95. Bottom-up and Top-down Approaches for This Report
Figure 96. Data Triangulation
Figure 97. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which companies rank high in the global Pharmaceutical Intermediates market?
The top companies in the global Pharmaceutical Intermediates market are Lonza、Catalent、Patheon.
What was the global market size of Pharmaceutical Intermediates in 2030?
What is the annual compound growth rate of the global Pharmaceutical Intermediates market size from 2024 to 2030?
Which region is expected to have the highest market share?
What was the global market size of Pharmaceutical Intermediates in 2024?
Related Reports
Global Pharmaceutical Intermediates Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Pharmaceutical intermediates are chemical material or chemical products, which could be applied in production of active pharmaceutical ingredients. Their production needs not production certification and they can be produced in ordinary chemical factory. There are many kinds of pharmaceutical intermediates, such as cephalosporin intermediates, vitamin intermediates, quinolones intermediates, steroid intermediates, etc.
Published Date: 2024-04-16
Pages: 173
USD 5900.00
(Single User License)
Global Pharmaceutical Intermediates Market Insights, Forecast to 2030
Pharmaceutical intermediates are chemical material or chemical products, which could be applied in production of active pharmaceutical ingredients. Their production needs not production certification and they can be produced in ordinary chemical factory. There are many kinds of pharmaceutical intermediates, such as cephalosporin intermediates, vitamin intermediates, quinolones intermediates, steroid intermediates, etc.
Published Date: 2024-04-07
Pages: 117
USD 4900.00
(Single User License)
Global Pharmaceutical Intermediates Market Research Report 2025
The global market for Pharmaceutical Intermediates was valued at US$ 205580 million in the year 2024 and is projected to reach a revised size of US$ 313420 million by 2031, growing at a CAGR of 6.3% during the forecast period.
Published Date: 2025-01-16
Pages: 99
USD 2900.00
(Single User License)
Pharmaceutical Intermediates- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Pharmaceutical Intermediates was estimated to be worth US$ 205580 million in 2024 and is forecast to a readjusted size of US$ 313420 million by 2031 with a CAGR of 6.3% during the forecast period 2025-2031.
Published Date: 2025-01-16
Pages: 143
USD 3950.00
(Single User License)
Global Pharmaceutical Intermediates Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Pharmaceutical Intermediates was estimated to be worth US$ 205580 million and is forecast to reach approximately US$ 313420 million by 2031 with a CAGR of 6.3% during the forecast period 2025-2031.
Published Date: 2025-03-28
Pages: 178
USD 5900.00
(Single User License)
Global Pharmaceutical Intermediates Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Pharmaceutical Intermediates market size was US$ 205580 million in 2024 and is forecast to a readjusted size of US$ 313420 million by 2031 with a CAGR of 6.3% during the forecast period 2025-2031.
Published Date: 2025-03-19
Pages: 108
USD 4250.00
(Single User License)
Global Pharmaceutical Intermediates Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Pharmaceutical Intermediates market is projected to grow from US$ 205580 million in 2024 to US$ 313420 million by 2031, at a CAGR of 6.3% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-09-11
Pages: 172
USD 4900.00
(Single User License)
Pharmaceutical Intermediates- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Pharmaceutical Intermediates was estimated to be worth US$ 217230 million in 2025 and is projected to reach US$ 331190 million, growing at a CAGR of 6.3% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 147
USD 3950.00
(Single User License)
Global Pharmaceutical Intermediates Market Research Report 2026
The global Pharmaceutical Intermediates market was valued at US$ 217230 million in 2025 and is anticipated to reach US$ 331190 million by 2032, at a CAGR of 6.3% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 136
USD 2900.00
(Single User License)
Global Pharmaceutical Intermediates Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Pharmaceutical Intermediates market size was US$ 217230 million in 2025 and is forecast to reach a readjusted size of US$ 331190 million by 2032 with a CAGR of 6.3% during the forecast period 2026-2032.
Published Date: 2026-01-04
Pages: 107
USD 4250.00
(Single User License)
Global Pharmaceutical Intermediates Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Pharmaceutical intermediates are chemical material or chemical products, which could be applied in production of active pharmaceutical ingredients. Their production needs not production certification and they can be produced in ordinary chemical factory. There are many kinds of pharmaceutical intermediates, such as cephalosporin intermediates, vitamin intermediates, quinolones intermediates, steroid intermediates, etc.
Published: 2024-04-16
Pages: 173
USD 5900.00 (Single User License)Global Pharmaceutical Intermediates Market Insights, Forecast to 2030
Pharmaceutical intermediates are chemical material or chemical products, which could be applied in production of active pharmaceutical ingredients. Their production needs not production certification and they can be produced in ordinary chemical factory. There are many kinds of pharmaceutical intermediates, such as cephalosporin intermediates, vitamin intermediates, quinolones intermediates, steroid intermediates, etc.
Published: 2024-04-07
Pages: 117
USD 4900.00 (Single User License)Global Pharmaceutical Intermediates Market Research Report 2025
The global market for Pharmaceutical Intermediates was valued at US$ 205580 million in the year 2024 and is projected to reach a revised size of US$ 313420 million by 2031, growing at a CAGR of 6.3% during the forecast period.
Published: 2025-01-16
Pages: 99
USD 2900.00 (Single User License)Pharmaceutical Intermediates- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Pharmaceutical Intermediates was estimated to be worth US$ 205580 million in 2024 and is forecast to a readjusted size of US$ 313420 million by 2031 with a CAGR of 6.3% during the forecast period 2025-2031.
Published: 2025-01-16
Pages: 143
USD 3950.00 (Single User License)Global Pharmaceutical Intermediates Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Pharmaceutical Intermediates was estimated to be worth US$ 205580 million and is forecast to reach approximately US$ 313420 million by 2031 with a CAGR of 6.3% during the forecast period 2025-2031.
Published: 2025-03-28
Pages: 178
USD 5900.00 (Single User License)Global Pharmaceutical Intermediates Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Pharmaceutical Intermediates market size was US$ 205580 million in 2024 and is forecast to a readjusted size of US$ 313420 million by 2031 with a CAGR of 6.3% during the forecast period 2025-2031.
Published: 2025-03-19
Pages: 108
USD 4250.00 (Single User License)Global Pharmaceutical Intermediates Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Pharmaceutical Intermediates market is projected to grow from US$ 205580 million in 2024 to US$ 313420 million by 2031, at a CAGR of 6.3% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-09-11
Pages: 172
USD 4900.00 (Single User License)Pharmaceutical Intermediates- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Pharmaceutical Intermediates was estimated to be worth US$ 217230 million in 2025 and is projected to reach US$ 331190 million, growing at a CAGR of 6.3% from 2026 to 2032.
Published: 2026-01-04
Pages: 147
USD 3950.00 (Single User License)Global Pharmaceutical Intermediates Market Research Report 2026
The global Pharmaceutical Intermediates market was valued at US$ 217230 million in 2025 and is anticipated to reach US$ 331190 million by 2032, at a CAGR of 6.3% from 2026 to 2032.
Published: 2026-01-04
Pages: 136
USD 2900.00 (Single User License)Global Pharmaceutical Intermediates Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Pharmaceutical Intermediates market size was US$ 217230 million in 2025 and is forecast to reach a readjusted size of US$ 331190 million by 2032 with a CAGR of 6.3% during the forecast period 2026-2032.
Published: 2026-01-04
Pages: 107
USD 4250.00 (Single User License)
CHOOSE LICENSE TYPE
USD 5600.00
USD 8400.00
USD 11200.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
MARKET SEGMENTATION
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report